Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function

Archives of Internal Medicine

Volumn 160, Issue 17, 2000, Pages 2645-2650

  Frances, Craig D ^a,b   Noguchi, Haruko ^c   Massie, Barry M ^b   Browner, Warren S ^b   McClellan, Mark ^c  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR EFFECT; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG USE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0034715226     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.17.2645     Document Type: Article

References (25)

1. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial: The SAVE Investigators
2. Outcome of acute myocardial infarction according to the specialty of the admitting physician
3. Determinants of appropriate use of angiotensin-converting enzyme inhibitors after acute myocardial infarction in persons ≤65 years of age
4. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
6. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
7. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
8. Trandolapril in patients with left ventricular dysfunction after myocardial infarction
9. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project
10. Regression models and life-tables
11. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: Results from the Cooperative Cardiovascular Project
12. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
13. Reducing bias in observational studies using subclassification on the propensity score
14. Maximum likelihood estimation from incomplete data via the EM algorithm
15. Maximum likelihood estimation via the ECM algorithm: A general frame work
16. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure
17. Neuroendocrinology of chronic renal failure and renal transplantation
18. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
19. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: Results of a double-blind, randomized comparative trial
20. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
21. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
22. Anti-platelet agents and survival: A cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial
23. Angiotensin-converting enzyme inhibitors and renal function in heart failure